Gray Nancy Ryan bought LGND
November 7, 2025 · Form 4 insider transaction
Gray Nancy Ryan bought 3,015 shares of Ligand Pharmaceuticals Incorporated at $73.57 per share, a transaction worth $221.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,015
Price
$73.57
Total value
$221.8K
InsiderGray Nancy Ryan
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 7, 2025
Filing dateNovember 12, 2025
Shares owned after11,109
OwnershipDirect
10b5-1 planNo
AmendedNo